GLP-1 therapy was supposed to be the game-changer—and for many, it is. But if your weight loss has slowed or stopped, you’re not alone. Here’s why plateaus happen, and how to overcome them.
The GLP-1 Plateau is Common—And Predictable
For most people, the first 3–6 months on a GLP-1 like semaglutide (Ozempic®, Wegovy®) or liraglutide (Saxenda®) bring rapid, noticeable weight loss.
Then, almost like clockwork, progress slows.
This isn’t a sign your medication “stopped working.” It’s your body adapting:
-
Lower appetite = lower calorie intake
Your body adjusts to this new energy level.
-
Lean muscle loss
Muscle burns more calories at rest than fat. Lose too much, and your metabolism slows.
-
Metabolic adaptation
Hormonal changes signal your body to conserve energy, making weight loss harder.
The Real Problem: Muscle and Metabolism
GLP-1 medications are effective appetite suppressants, but they don’t protect muscle.
In fact, studies show a significant portion of weight lost on GLP-1s comes from lean mass—not just fat.
This matters because:
-
Muscle is your metabolic engine
-
Less muscle = fewer calories burned
-
Lower metabolism = harder fat loss and easier regain
Your plateau isn’t just about calories—it’s about composition.
Breaking Through: Support Your Body Where GLP-1s Can’t
This is where targeted nutritional support matters.
SLM+ by STAAR LABS was designed specifically for this stage of the journey:
-
Supports healthy glucose metabolism to smooth energy dips and plateaus
-
Helps protect lean muscle during calorie restriction
-
Promotes continued fat loss by keeping metabolism active
-
Reduces the risk of rebound weight gain when progress slows
Instead of simply waiting out the plateau, you can actively support your body to keep moving forward.
The Bottom Line
If you’ve hit a wall on GLP-1 therapy, it’s not failure—it’s physiology.
Your medication is doing its job. But to keep making progress, you need to address the gaps in the protocol.
That’s exactly why we developed SLM+—to give every GLP-1 patient the metabolic and muscular support they need to reach their goals and keep them.
👉 Ready to break your plateau?
Learn how SLM+ can complete your GLP-1 protocol:
Medical Disclaimer:
STAAR LABS is not a licensed pharmacy, medical provider, or drug manufacturer. The information provided is for educational purposes only and is not intended to diagnose, treat, cure, or prevent any disease. SLM+ is a dietary supplement and is not intended to replace prescription medications or medical advice. Patients should consult their licensed healthcare provider before making any changes to their medical treatment, diet, or supplement use.
Trademark Disclaimer:
Ozempic®, Wegovy®, and Saxenda® are registered trademarks of Novo Nordisk A/S.
Mounjaro® and Zepbound® are registered trademarks of Eli Lilly and Company.
STAAR LABS is not affiliated with, sponsored by, or endorsed by Novo Nordisk A/S or Eli Lilly and Company. References to these products are for informational purposes only to describe commonly prescribed GLP-1 therapies.
Research & Innovation Disclosure:
STAAR LABS collaborates with clinics, pharmacies, and healthcare professionals to advance innovation in real-world metabolic health protocols. We welcome research partners committed to improving outcomes through evidence-based nutraceutical and pharmaceutical strategies.